AI in Life Sciences: Faster Cures for Viral Disease

COVID-19 is upending life as we know it. The potential effect of this viral disease on mortality and public health, as well as the lasting socioeconomic impact of the crisis, is unfathomable. To mitigate the wide-scale impact of this growing pandemic, our hopes are trained on a vaccine, prophylactic or curative, and the life sciences […]

Read More

Financial Institutions & COVID-19: How to Lead through the Crisis and Prepare for the Next One

The global response to the ongoing COVID-19 pandemic and local social distancing efforts has sent massive supply- and demand-side shocks to retailers, automakers, healthcare companies, and travel and hospitality purveyors. No sector is immune. In fact, banks are already feeling the downstream impact and bracing for longer-term consequences. In our discussions with banks and diversified […]

Read More

Balancing Health Data Sharing with Protections: Great Medicine for Quashing Epidemics

In Singapore, public health officials publish online the locations of the residence, workplace and places recently visited by each newly confirmed coronavirus patient so that other citizens can take appropriate action to protect themselves and their loved ones. In Taiwan, health insurance and immigration agencies combined the 14-day travel histories of local and foreign residents […]

Read More

The Future of Work. At Home

The coronavirus is changing our lives before our very eyes. How and where we work may be among the biggest disruptions. If you’re dealing with the disorientation of suddenly having to work from home, and are not quite sure what’s hit you, here are a few tips from someone who’s been doing it, happily and […]

Read More

A Virus in a Viral Age

Unless you’ve been totally off the grid, you’ve probably noticed the world is consumed with the topic of coronavirus. As of this writing, I am well thank [insert name of your personal deity here] and have felt no ill effects (thank you for asking) as I’ve traveled from Boston to Austin to Boston to London to […]

Read More

LIBOR Phase-out for Mortgage Lenders Just Got Closer

Sometimes it takes a nudge to make a deadline feel real. The mortgage industry got a reminder of the work ahead of it when Fannie Mae and Freddie Mac recently announced they’ll stop accepting adjustable-rate mortgages (ARM) tied to the London interbank offered rate (LIBOR) by the end of 2020. That’s a full year ahead […]

Read More

Don’t Put Mothers In A Closet

In the months that I’ve been back at work as a nursing mom, I’ve seen quite a few designated lactation spaces in different companies’ offices.  While every room included a chair, a table near the chair and a lock on the door, most of them felt like the individuals creating the space had little appreciation […]

Read More

Capitalizing on the Brand Content Opportunity

Five years ago, I stood up at Social Media Week in Copenhagen and made a prediction: that by the year 2020, brand content would always be highly informed by personal, transactional, behavioral and contextual data. I’m hoping there isn’t a video of that event floating around because, embarrassingly, that hasn’t really happened. Think about it: How […]

Read More

Value-Based Care in Life Sciences: What’s It Worth to You?

Just one of the many changes rippling through the life sciences industry is the gradual but inexorable shift of value-based care (VBC) becoming a leading means of healthcare insurance reimbursement. According to our recently sponsored research, as many as 150 biopharmaceutical drugs  are covered by value-based contracts, with a projected growth rate of 15% to […]

Read More
X Close